Literature DB >> 17216229

Physicochemical and MRI characterization of Gd3+-loaded polyamidoamine and hyperbranched dendrimers.

Zoltán Jászberényi1, Loïck Moriggi, Philipp Schmidt, Claudia Weidensteiner, Rainer Kneuer, André E Merbach, Lothar Helm, Eva Tóth.   

Abstract

Generation 4 polyamidoamine (PAMAM) and, for the first time, hyperbranched poly(ethylene imine) or polyglycerol dendrimers have been loaded with Gd3+ chelates, and the macromolecular adducts have been studied in vitro and in vivo with regard to MRI contrast agent applications. The Gd3+ chelator was either a tetraazatetracarboxylate DOTA-pBn4- or a tetraazatricarboxylate monoamide DO3A-MA3- unit. The water exchange rate was determined from a 17O NMR and 1H Nuclear Magnetic Relaxation Dispersion study for the corresponding monomer analogues [Gd(DO3A-AEM)(H2O)] and [Gd(DOTA-pBn-NH2)(H2O)]- (kex298=3.4 and 6.6x10(6) s-1, respectively), where H3DO3A-AEM is {4-[(2-acetylaminoethylcarbamoyl)methyl]-7,10-bis(carboxymethyl-1,4,7,10-tetraazacyclododec-1-yl)}-acetic acid and H4DOTA-pBn-NH2 is 2-(4-aminobenzyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid. For the macromolecular complexes, variable-field proton relaxivities have been measured and analyzed in terms of local and global motional dynamics by using the Lipari-Szabo approach. At frequencies below 100 MHz, the proton relaxivities are twice as high for the dendrimers loaded with the negatively charged Gd(DOTA-pBn)- in comparison with the analogous molecule bearing the neutral Gd(DO3A-MA). We explained this difference by the different rotational dynamics: the much slower motion of Gd(DOTA-pBn)--loaded dendrimers is likely related to the negative charge of the chelate which creates more rigidity and increases the overall size of the macromolecule compared with dendrimers loaded with the neutral Gd(DO3A-MA). Attachment of poly(ethylene glycol) chains to the dendrimers does not influence relaxivity. Both hyperbranched structures were found to be as good scaffolds as regular PAMAM dendrimers in terms of the proton relaxivity of the Gd3+ complexes. The in vivo MRI studies on tumor-bearing mice at 4.7 T proved that all dendrimeric complexes are suitable for angiography and for the study of vasculature parameters like blood volume and permeability of tumor vessels.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17216229     DOI: 10.1007/s00775-006-0197-3

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.862


  26 in total

1.  Lanthanide ions as magnetic resonance imaging agents. Nuclear and electronic relaxation properties. Applications.

Authors:  Lothar Helm; Eva Tóth; André E Merbach
Journal:  Met Ions Biol Syst       Date:  2003

2.  Towards the rational design of magnetic resonance imaging contrast agents: isolation of the two coordination isomers of lanthanide DOTA-type complexes.

Authors:  Mark Woods; Zoltan Kovacs; Shanrong Zhang; A Dean Sherry
Journal:  Angew Chem Int Ed Engl       Date:  2003       Impact factor: 15.336

3.  Development of a tumor-targeting MR contrast agent using the high-affinity folate receptor: work in progress.

Authors:  S D Konda; M Aref; M Brechbiel; E C Wiener
Journal:  Invest Radiol       Date:  2000-01       Impact factor: 6.016

Review 4.  Polymer architecture and drug delivery.

Authors:  Li Yan Qiu; You Han Bae
Journal:  Pharm Res       Date:  2006-01-11       Impact factor: 4.200

5.  Dendrimeric Gd(III) complex of a monophosphinated DOTA analogue: optimizing relaxivity by reducing internal motion.

Authors:  Jakub Rudovsky; Petr Hermann; Mauro Botta; Silvio Aime; Ivan Lukes
Journal:  Chem Commun (Camb)       Date:  2005-03-18       Impact factor: 6.222

Review 6.  PAMAM dendrimer based macromolecules as improved contrast agents.

Authors:  Vincent J Venditto; Celeste Aida S Regino; Martin W Brechbiel
Journal:  Mol Pharm       Date:  2005 Jul-Aug       Impact factor: 4.939

7.  Magnetic resonance angiography with gadomer-17. An animal study original investigation.

Authors:  Q Dong; D R Hurst; H J Weinmann; T L Chenevert; F J Londy; M R Prince
Journal:  Invest Radiol       Date:  1998-09       Impact factor: 6.016

8.  Inversion recovery snapshot FLASH MR imaging.

Authors:  A Haase; D Matthaei; R Bartkowski; E Dühmke; D Leibfritz
Journal:  J Comput Assist Tomogr       Date:  1989 Nov-Dec       Impact factor: 1.826

9.  Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications.

Authors:  R Esfand; D A. Tomalia
Journal:  Drug Discov Today       Date:  2001-04-01       Impact factor: 7.851

10.  Rotational dynamics account for pH-dependent relaxivities of PAMAM dendrimeric, Gd-based potential MRI contrast agents.

Authors:  Sabrina Laus; Angélique Sour; Robert Ruloff; Eva Tóth; André E Merbach
Journal:  Chemistry       Date:  2005-05-06       Impact factor: 5.236

View more
  16 in total

1.  Synthesis and relaxometric studies of a dendrimer-based pH-responsive MRI contrast agent.

Authors:  M Meser Ali; Mark Woods; Peter Caravan; Ana C L Opina; Marga Spiller; James C Fettinger; A Dean Sherry
Journal:  Chemistry       Date:  2008       Impact factor: 5.236

2.  Cell-permeable MR contrast agents with increased intracellular retention.

Authors:  Paul J Endres; Keith W MacRenaris; Stefan Vogt; Thomas J Meade
Journal:  Bioconjug Chem       Date:  2008-09-20       Impact factor: 4.774

Review 3.  Dendrimer nanoscaffolds for potential theranostics of prostate cancer with a focus on radiochemistry.

Authors:  Su-Tang Lo; Amit Kumar; Jer-Tsong Hsieh; Xiankai Sun
Journal:  Mol Pharm       Date:  2013-01-24       Impact factor: 4.939

4.  Metal Chelating Crosslinkers Form Nanogels with High Chelation Stability.

Authors:  Jacques Lux; Minnie Chan; Luce Vander Elst; Eric Schopf; Enas Mahmoud; Sophie Laurent; Adah Almutairi
Journal:  J Mater Chem B       Date:  2013-12-14       Impact factor: 6.331

5.  New nanosized biocompatible MR contrast agents based on lysine-dendri-graft macromolecules.

Authors:  Mikako Ogawa; Celeste A S Regino; Bernardo Marcelino; Mark Williams; Nobuyuki Kosaka; L Henry Bryant; Peter L Choyke; Hisataka Kobayashi
Journal:  Bioconjug Chem       Date:  2010-05-19       Impact factor: 4.774

6.  Development and application of a multimodal contrast agent for SPECT/CT hybrid imaging.

Authors:  Jason M Criscione; Lawrence W Dobrucki; Zhen W Zhuang; Xenophon Papademetris; Michael Simons; Albert J Sinusas; Tarek M Fahmy
Journal:  Bioconjug Chem       Date:  2011-09-06       Impact factor: 4.774

7.  Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases.

Authors:  Emilia S Olson; Tao Jiang; Todd A Aguilera; Quyen T Nguyen; Lesley G Ellies; Miriam Scadeng; Roger Y Tsien
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205

Review 8.  Advances in gadolinium-based MRI contrast agent designs for monitoring biological processes in vivo.

Authors:  Jacques Lux; A Dean Sherry
Journal:  Curr Opin Chem Biol       Date:  2018-05-09       Impact factor: 8.822

9.  Associating a negatively charged GdDOTA-derivative to the Pittsburgh compound B for targeting Aβ amyloid aggregates.

Authors:  André F Martins; Alexandre C Oliveira; Jean-François Morfin; Douglas V Laurents; Éva Tóth; Carlos F G C Geraldes
Journal:  J Biol Inorg Chem       Date:  2015-11-27       Impact factor: 3.358

10.  Protein polymer MRI contrast agents: Longitudinal analysis of biomaterials in vivo.

Authors:  Lindsay S Karfeld-Sulzer; Emily A Waters; Ellen K Kohlmeir; Hermann Kissler; Xiaomin Zhang; Dixon B Kaufman; Annelise E Barron; Thomas J Meade
Journal:  Magn Reson Med       Date:  2011-01       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.